Patent · US Active

Multi-antigenic alphavirus replicon particles and methods

US8617533B2 · kind B2 · utility

11Cited by
59References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2008
Grant dateDec 31, 2013
Priority date
Expiry dateFeb 2, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/36152
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Viral replicon selected nucleic acid expression libraries are useful for analyzing multiple antigens associated with a parasite, pathogen or neoplasia or for preparing immunogenic compositions for generating immune responses specific for the parasite, pathogen or neoplasia. Alphavirus replicon particles representative of the nucleic acid expression library are preferred. The nucleic acid library can be a random library, or it can be prepared after a selection step, for example, by differential hybridization prior to cloning into the replicon vector.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.